Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ting Wu, MD MSc
Mythic Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
55 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Blacktown Hospital
Blacktown, New South Wales, Australia
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Cancer Research Sa
Adelaide, South Australia, Australia
- Queen Elizabeth Hospital
Adelaide, South Australia, Australia
- Institut Bergonié-Bordeaux
Bordeaux, France
- Centre Léon Bérard - Lyon
Lyon, France
- Aphm - Hopital de la Timone
Marseille, France
- Institut de Cancérologie de L'Ouest (ico Institute)-St Herblain
Nantes, France
- Institut Curie (lead)
Paris, France
- Oncopole Claudius Regaud, Iuct-Oncopole
Toulouse, France
- Gustave Roussy Institute
Villejuif, France
- Seoul National University Hospital
Seoul, MA, South Korea
- Kosin Univ. Gospel Hospital
Busan, South Korea
- Chungbuk National Univ. Hospital
Incheon, South Korea
- Gachon University
Seongnam, South Korea
- National Cancer Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- St. Vincent Hospital
Suwon, South Korea
- Instituto Oncológico Dr Rosell (ior) - Hospital Univ. Dexeus
Barcelona, Spain
- Start Barcelona-Hm Ciocc Early Phase Program
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Ramón Y Cajal
Madrid, Spain
- Start Centro Integral Oncologico Calra Campal
Madrid, Spain
- Start Madrid-Fjd, Hospital Fundación Jiménez Díaz
Madrid, Spain
- Hospital Quirónsalud Málaga
Málaga, Spain
- Hospital Clinico Universitario de Valencia
Valencia, Spain
- Hospital Universitario Lozano Blesa
Zaragoza, Spain
- Taichung Veterans General Hospital
Taichung, MA, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- National Taiwan University Cancer Centre
Taipei, Taiwan
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Medical University Hospital
Taipei, Taiwan
- National Taiwan University Hospital Hsin-Chu Branch
Zhubei, Taiwan
- Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
- University College London Hospitals Nhs Foundation Trust
London, United Kingdom
- Newcastle Upon Tyne Hospital (nhs)
Newcastle, United Kingdom
- Churchill Hospital - Oxford University Hospitals
Oxford, United Kingdom
- University of California San Diego
La Jolla, California, United States
- Ucla
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Mar 2023
- Primary completion
- 31 Oct 2025
- Completion
- 7 Nov 2025
- Last update posted
- 16 Dec 2025
- Registered enrollment
- 227
- Registry id
- NCT05652868
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.